Shiferman Gregory L. 4
4 · Sage Therapeutics, Inc. · Filed Mar 26, 2025
Insider Transaction Report
Form 4
Shiferman Gregory L.
See Remarks
Transactions
- Tax Payment
Common Stock
2025-03-24$8.21/sh−79$649→ 30,680 total
Footnotes (1)
- [F1]On March 24, 2025, the reporting person vested 235 shares of time-based restricted stock units (RSUs) granted on October 28, 2021 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vested 25% on September 24, 2022, and vests quarterly thereafter in twelve equal installments. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.